United States: CFIUS Pilot Program: Immediate Implications For Investors And Investment Targets

On October 10, 2018, the U.S. Department of the Treasury issued temporary regulations—a "pilot program"—to implement certain provisions of the Foreign Investment Risk Review Modernization Act ("FIRRMA"), signed into law by President Donald Trump on August 13, 2018.1 Among other things, FIRRMA expanded the jurisdiction of the Committee on Foreign Investment in the United States ("CFIUS" or the "Committee") to include new categories of covered transactions and authorized CFIUS to make certain filings mandatory.

The announcement of the October 10 pilot program represents a dramatic and rapid assertion by CFIUS of new authority granted to it under FIRRMA. Under the pilot program, non-controlling foreign investments in certain U.S. industries (electronics, chemical, and semiconductor manufacturing, and research and development in biotechnology, among others)—which, prior to FIRRMA, were outside the scope of the Committee's jurisdiction—will be subject to mandatory CFIUS notification (at risk of significant penalty). As detailed below, the pilot program may have immediate consequences for active transactions that have not yet progressed to the signing stage.

I. Overview of CFIUS and FIRRMA

CFIUS is an interagency committee with authority to review foreign investments in the United States. The Committee received authority to review foreign transactions following passage of the Exon-Florio Amendment, 50 U.S.C. § 2170, which amended Section 721 of the Defense Production Act of 1950 and granted the President authority to block foreign investments in the United States when "the transaction threatens to impair the national security of the United States."

CFIUS has authority to review any "covered transaction," which historically has meant "any transaction . . . by or with any foreign person[] which could result in control of a U.S. business by a foreign person." 31 C.F.R. § 800.207. FIRRMA—which was motivated by the perception that the existing CFIUS regime was ill-equipped to handle new threats to U.S. national security posed by foreign investment—introduced key reforms to the Committee's review authority and process:

  • Extended CFIUS's jurisdiction to any non-passive foreign investment in a U.S. "critical technology" company. Under FIRRMA, any foreign investment in a U.S. "critical technology" company that is not purely passive is a "covered transaction" subject to CFIUS's review, even if the foreign investor does not acquire "control" of the U.S. business. Importantly, "passive investment" is narrowly interpreted, and an investment with certain specified rights (e.g., access to non-public technical information, board or board observer rights, etc.) does not qualify.
  • Broadened the definition of "critical technology." FIRRMA expanded the definition of critical technology to include not only items covered by the United States Munitions List, items on the Commerce Control List, certain nuclear-related materials, and items covered by the Select Agents and Toxins regulations, 31 C.F.R. § 800.209, but also other emerging and foundational technologies with potential national security implications.
  • Made certain filings mandatory. Prior to FIRRMA, the CFIUS regime was entirely voluntary, meaning that the parties to covered transactions were not required to provide notice of the transactions to the Committee. FIRRMA introduced a mandatory filing requirement for certain transactions involving foreign government-affiliated investors, and also authorized CFIUS to develop mandatory filing requirements for certain investments in critical technology companies.
  • Authorized CFIUS to conduct pilot programs to implement aspects of FIRRMA that did not take effect upon enactment. Certain provisions of FIRRMA, such as the expanded definition of "critical technology," took effect immediately. Other provisions—including the extension of CFIUS's jurisdiction to certain non-passive investments—will not take effect until the earlier of (1) the date that is 18 months after enactment, or (2) 30 days after the Secretary of the Treasury certifies that the new regulations and necessary organizational resources called for by the bill are in place. Importantly, section 1727(c) of FIRRMA authorizes CFIUS to conduct "pilot programs" to implement earlier those aspects of FIRRMA that did not take immediate effect.

II. The Pilot Program

The pilot program will take effect on November 10, 2018 and will remain in effect until final regulations implementing FIRRMA are promulgated. The Interim Rule (1) expands CFIUS's jurisdiction to certain non-passive investments in critical technology companies ("pilot program covered investments"); and (2) introduces a mandatory notification requirement for transactions involving critical technology companies. The Committee implemented the pilot program "expeditiously," observing that "[d]elaying effectiveness of the interim rule would create an unacceptable risk of erosion of U.S. technological superiority."2

Expansion of CFIUS's Jurisdiction

Under the Interim Rule, CFIUS will be authorized to review any "pilot program covered transaction." The term "pilot program covered transaction" includes (1) transactions in which a foreign person could acquire control of a "pilot program U.S. business"; and (2) pilot program covered investments. 31 C.F.R. § 801.210. The former category of transactions—involving controlling investments in U.S. business by foreign persons—is within the scope of CFIUS's existing jurisdiction. The latter category of transactions—pilot program covered investments—historically has been outside the scope of CFIUS's jurisdiction. A pilot program covered investment includes any investment, direct or indirect, by a foreign person in an unaffiliated pilot program U.S. business that could not result in control by the foreign person of the U.S. business, but that does afford the foreign person:

  • Access to any material nonpublic technical information in the possession of the pilot program U.S. business;
  • Membership or observer rights on the board of directors or equivalent governing body of the pilot program U.S. business or the right to nominate an individual to a position on the board of directors or equivalent governing body of the pilot program U.S. business; or
  • Any involvement, other than through voting of shares, in substantive decision-making of the pilot program U.S. business regarding the use, development, acquisition, or release of critical technology.

Id. § 801.209.

The term "pilot program U.S. business" includes any U.S. business that produces, designs, tests, manufactures, fabricates or develops a critical technology that is either utilized in connection with the U.S. business's activity in one or more "pilot program industry" or designed by the U.S. business specifically for use in one or more "pilot program industry."3 Id. § 801.213. These industries include, inter alia, aircraft, electronics, military, nuclear, chemical, and semiconductor manufacturing.4 According to CFIUS, the list of pilot program industries was "carefully developed by the U.S. government to narrowly scope the pilot program to include only those industries in which the threat of erosion of technological superiority from some foreign direct investment requires immediate action."5

Under the Interim Rule, any transaction involving a non-passive foreign investment in one of the industries covered by the pilot program is now subject to CFIUS's jurisdiction. 31 C.F.R. § 801.302. This includes, for example, a 4% investment that grants board observer rights, as well as an increase from a 4% to 9% investment that grants access to material nonpublic technical information. Id.

The Interim Rule sets forth three noteworthy exceptions:

  • First, a transaction is not a pilot program covered transaction if (1) the U.S. business does not deal in critical technology, even if it is in a pilot program industry, (2) the transaction does not afford the foreign investor either control rights or any of the rights set forth in § 801.209, or (3) the U.S. business is not in a pilot program industry, regardless of the technology it produces. Id. § 801.303.
  • Second, an indirect investment by a foreign person in a pilot program U.S. business through an investment fund that affords the foreign person membership as a limited partner on the equivalent of an advisory board does not qualify as a pilot program covered transaction if the foreign person is not the general partner and has no control rights. Id. § 801.304.
  • Third, no investment involving air carriers holding a certificate issued under 49 U.S.C. § 41102 shall qualify.

Mandatory Filing Requirement

The parties to every pilot program covered transaction must make a filing with CFIUS, marking the first time in the Committee's history that a filing has been mandatory. The parties have the option of submitting (1) a joint voluntary notice under existing CFIUS rules, 31 C.F.R. §§ 800.401, 402; or (2) an abbreviated declaration. Id. § 801.401(a), (b). Parties to pilot program covered transactions must file either an abbreviated declaration or a voluntary notice on November 10, or promptly thereafter, if the completion date of the transaction is between November 10 and December 25, 2018, and within 45 days before the completion of the transaction otherwise. Id. § 801.401(c)(2).

The contents of the abbreviated declaration—which, pursuant to FIRRMA, should "not generally exceed 5 pages in length" but which in practice may prove to be longer—must nevertheless include a significant amount of information, including a description of the transaction, a statement of the basis for the transaction being deemed a pilot program covered transaction, information about the U.S. business (including its industry, technology, and U.S. government contacts), and information about the foreign person (including its ownership and any foreign government connections). Id. § 801.403.6

Abbreviated declarations will undergo a 30-day review period. Id. § 801.404. During the 30-day review period, all inquiries from CFIUS must be answered within two business days or the Committee will reject the declaration. Id. § 801.406(a)(3). At the conclusion of the 30-day review period, CFIUS may (1) request that the parties file a full, joint voluntary notice; (2) indicate that CFIUS is not able to complete action on the basis of the declaration and invite further correspondence; (3) initiate an investigation of the transaction; or (4) clear the transaction. Id. § 801.407.

Underscoring the mandatory nature of the filing, the Interim Rule incorporates a penalty provision. Any person who fails to comply with the requirements of the pilot program to file either a joint voluntary notice or an abbreviated declaration may face a civil penalty "not to exceed the value of the pilot program covered transaction." Id. § 801.409(a).

III. Immediate Implications

Significant Increase in CFIUS Filings

As an initial matter, the Interim Rule will significantly expand the number and scope of transactions subject to CFIUS review. Notwithstanding that the Interim Rule characterizes the definition of "pilot program U.S. business" as "narrowly scoped," the list of pilot program industries is expansive.7 In addition, the definition of "critical technologies," as recently expanded by FIRRMA, is (purposefully) broad and accords CFIUS considerable discretion to determine that a particular transaction implicates "critical technology" and, therefore, may pose a risk to U.S. national security.8 The breadth of these definitions—in conjunction with the introduction of a mandatory filing requirement, backed by a daunting penalty mechanism, and a lack of post-FIRRMA precedent—is likely to result in a significant and immediate increase in CFIUS filings. There is in particular likely to be considerable urgency over the next month for a certain subset of transactions, as any unsigned transaction—see infra—currently scheduled to close between November 10 and December 25 must be reported by "November 10, 2018, or promptly thereafter[.]" 31 C.F.R. § 800.401(c)(1).

Deterrence of Foreign Investments

The introduction of a mandatory filing requirement foreseeably will deter foreign investment in companies that are—or arguably may be construed as—critical technology companies. The compulsory disclosure of information regarding the foreign investor, as well as uncertainty regarding the scope (and attendant costs) of the abbreviated declaration process, inevitably will alter the CFIUS risk calculus for many foreign investors. Consistent with FIRRMA's overarching goals, the consequences are likely to be felt most acutely by (1) foreign investors with government affiliations, for which the disclosure requirement may be a significant deterrent; and (2) early stage investors, for which the uncertainty and added costs associated with the abbreviated declaration process may render such investments cost-prohibitive.

The Pilot Program Will Affect Active Transactions

The Interim Rule "do[es] not apply to [1] transactions for which the completion date is prior to the pilot program effective date, or [2] transactions for which the parties have executed a binding written agreement or other document establishing the material terms of the transaction prior to October 11, 2018."9 As the pre-investment due diligence process frequently can extend weeks, months, or even years, there is a significant volume of transactions—including both new investments and increases in existing equity or control rights—that now will be subject to a mandatory CFIUS filing requirement. As a result, parties to active transactions are likely to incur new costs that, in some cases, may undermine the original investment thesis. Relatedly, prospective investors may be required to re-assess and, in some cases, overhaul their investment pipelines, to account for the new jurisdictional standard.

The Changes Are Not Final

As its name suggests, the pilot program is not permanent. The Interim Rule states that:

The scope, procedures, and terms used in the pilot program are specific to the pilot program and subject to change in the proposed final rule implementing FIRRMA. . . . [T]he pilot program implemented through these regulations will end no later than March 5, 2020, the date that is 570 days after the enactment of FIRRMA. These regulations will be amended, replaced, or removed no later than the date on which the pilot program ends.10

As a result, in addition to re-assessing existing opportunities, investors must continue to follow FIRRMA implementation developments, which may necessitate further revisions to investment and due diligence protocols (the timing of which is relatively uncertain).

IV. Conclusion

FIRRMA represented the most significant effort to revise the CFIUS process in more than a decade. The U.S. Department of the Treasury's announcement of the pilot program signals that CFIUS intends to quickly assert its new authority under the law to restrict certain types of foreign investment in the United States. The changes introduced by the Interim Rule are significant, and almost immediately applicable. Accordingly, dealmakers would be well advised to assess the applicability of the pilot program to pending and future transactions.


1. Determination and Temporary Provisions Pertaining to a Pilot Program to Review Certain Transactions Involving Foreign Persons and Critical Technologies (to be codified at 31 C.F.R. § 801), https://home.treasury.gov/system/files/206/FR-2018-22182_1786904.pdf [hereinafter "Interim Rule"].

2. Id. at 9.

3. The term "pilot program industry" includes any company in one of 27 industries, as defined by their North American Industry Classification System ("NAICS") code. Id. § 801.212; Id. § 801 Annex A.

4. The complete list includes: Aircraft Manufacturing (NAICS Code 336411); Aircraft Engine and Engine Parts Manufacturing (NAICS Code 336412); Alumina Refining and Primary Aluminum Production (NAICS Code 331313); Ball and Roller Bearing Manufacturing (NAICS Code 332991); Computer Storage Device Manufacturing (NAICS Code 334112); Electronic Computer Manufacturing (NAICS Code 334111); Guided Missile and Space Vehicle Manufacturing (NAICS Code 336414); Guided Missile and Space Vehicle Propulsion Unit and Propulsion Unit Parts Manufacturing (NAICS Code 336415); Military Armored Vehicle, Tank, and Tank Component Manufacturing (NAICS Code 336992); Nuclear Electric Power Generation (NAICS Code 221113); Optical Instrument and Lens Manufacturing (NAICS Code 333314); Other Basic Inorganic Chemical Manufacturing (NAICS Code 325180); Other Guided Missile and Space Vehicle Parts and Auxiliary Equipment Manufacturing (NAICS Code 336419); Petrochemical Manufacturing (NAICS Code 325110); Powder Metallurgy Part Manufacturing (NAICS Code 332117); Power Distribution, and Specialty Transformer Manufacturing (NAICS Code 335311); Primary Battery Manufacturing (NAICS Code 335912); Radio and Television Broadcasting and Wireless Communications Equipment Manufacturing (NAICS Code 334220); Research and Development in Nanotechnology (NAICS Code 541713); Research and Development in Biotechnology (except Nanobiotechnology) (NAICS Code 541714); Secondary Smelting and Alloying of Aluminum (NAICS Code 331314); Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing (NAICS Code 334511); Semiconductor and Related Device Manufacturing (NAICS Code 334413); Semiconductor Machinery Manufacturing (NAICS Code 333242); Storage Battery Manufacturing (NAICS Code 335911); Telephone Apparatus Manufacturing (NAICS Code 334210); and Turbine and Turbine Generator Set Units Manufacturing (NAICS Code 333611). 31 C.F.R. § 801 Annex A.

5. Interim Rule at 9.

6. Should the parties choose to file a joint voluntary notice, the parties must include similar information regarding why the transaction is a pilot program covered transaction, in addition to the information that is ordinarily required. 31 C.F.R. § 800.503.

7. Interim Rule at 13.

8. "Critical technologies" previously was defined to include items covered by the United States Munitions List, items on the Commerce Control List, certain nuclear-related materials, and items covered by the Select Agents and Toxins regulations. 31 C.F.R. § 800.209. Pursuant to FIRRMA, the term now also includes "[o]ther emerging technologies that could be essential for maintaining or increasing the technological advantage of the United States over countries of special concern with respect to national defense, intelligence, or other areas of national security, or gaining such an advantage over such countries in areas where such an advantage may not currently exist."

9. Interim Rule at 11.

10. Id. at 10-11.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions